Market Overview:
The global acarbose API market is expected to grow at a CAGR of XX% and reach a value of USD XX million by 2030. The market is segmented on the basis of type, application and region. On the basis of type, the market is segmented into microbial fermentation process and chemical synthesis process. The microbial fermentation process segment dominates the global acarbose API market with a share of XX%. On the basis of application, the market is divided into acarbose tablets, acarbose capsules and chewable tables. Acarbose capsules are expected to grow at a CAGR of XX% during 2018-2030. Geographically, North America dominates the global acarbose API market with a shareofXX%.
Product Definition:
Acarbose API is an important drug used for the treatment of diabetes. It helps to control blood sugar levels by slowing the digestion of carbohydrates in the intestine. This drug is available as a tablet and can be taken with or without food.
Microbial Fermentation Process:
Microbial fermentation process is used for the production of various chemicals such as antibiotics, enzymes, and vitamins. The microbial fermentation process involves the use of microorganisms (bacteria or yeast) to convert raw materials into useful products. Microbial fermentation has been an important technology in organic chemical manufacturing since the beginning of industrialization.
The global microbial fermentation market size was valued at USD 2,867 million in 2016.
Chemical Synthesis Process:
The chemical synthesis process is used to make chemicals from scratch. It's a very old technology and has been around for quite some time. Chemical synthesis can be done either by using raw materials that are available in the market or by using compounds that are made in a lab environment. In both cases, it involves mixing an acid with an amine, which then forms a salt and releasing carbon dioxide as waste along with other products.
Application Insights:
The global acarbose API market is segmented on the basis of application as acarbose tables, acarbose capsules, and chewable tables. Acarbose tablets were the largest revenue-generating segment in 2017 owing to its wide usage for treating type 2 diabetes. It works by lowering blood sugar levels in patients suffering from diabetes mellitus. The capsules version of this drug is expected to witness significant growth over the forecast period owing to its use as an alternative therapy for type 2 diabetes and other related metabolic disorders.
The demand for acarbose tablets was highest in Asia Pacific followed by North America due largely to high incidences of obesity coupled with unhealthy eating habits among people living in these regions which are majorly responsible for increasing prevalence rates of metabolic disorders such as insulin resistance syndrome (ISS) and impaired glucose tolerance (IGT). These aforementioned factors are anticipated to drive product demand over the forecast period thus contributing towards overall market growth during this timeframe.
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to high product demand from countries, such as China and India. In addition, increasing cases of diabetes are also expected to drive product demand over the forecast period. For instance, according to a recent study published by NCBI; around 60% of diabetic patients in China were found to be living with undiagnosed diabetes and 80 million people were estimated having diabetes in 2016 which is projectededto reach 123 million by 2045 if no effective measures are taken against it.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is primarily due to the changing lifestyle and dietary habits of people across the world. According to a study by the International Diabetes Federation, there were 415 million people with diabetes in 2015 and this number is expected to reach 642 million by 2030. This will create a large pool of patients who will require treatment for their condition, thereby driving demand for acarbose API.
- Rising awareness about diabetes: There has been a significant increase in awareness about diabetes in recent years, thanks to various campaigns and initiatives undertaken by governments and healthcare organizations worldwide. As a result, more people are now aware of the risks associated with uncontrolled blood sugar levels and are seeking treatment for their condition. This will lead to an increase in demand for acarbose API over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Acarbose API Market Research Report
By Type
Microbial Fermentation Process, Chemical Synthesis Process
By Application
Acarbose Tables, Acarbose Capsules, Acarbose Chewable Tables
By Companies
Huadong Medicine Co.,Ltd, Zhejiang Hisun Pharmaceutical Co., Ltd., Bayer, Livzon New North River Pharmaceutical Co., Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
143
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Acarbose API Market Report Segments:
The global Acarbose API market is segmented on the basis of:
Types
Microbial Fermentation Process, Chemical Synthesis Process
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Acarbose Tables, Acarbose Capsules, Acarbose Chewable Tables
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Huadong Medicine Co.,Ltd
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- Bayer
- Livzon New North River Pharmaceutical Co., Ltd
Highlights of The Acarbose API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Microbial Fermentation Process
- Chemical Synthesis Process
- By Application:
- Acarbose Tables
- Acarbose Capsules
- Acarbose Chewable Tables
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Acarbose API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Acarbose API is a prescription medication used to treat type 2 diabetes. It works by reducing the amount of sugar in the blood.
Some of the major players in the acarbose api market are Huadong Medicine Co.,Ltd, Zhejiang Hisun Pharmaceutical Co., Ltd., Bayer, Livzon New North River Pharmaceutical Co., Ltd.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Acarbose API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Acarbose API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Acarbose API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Acarbose API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Acarbose API Market Size & Forecast, 2018-2028
4.5.1 Acarbose API Market Size and Y-o-Y Growth
4.5.2 Acarbose API Market Absolute $ Opportunity
Chapter 5 Global Acarbose API Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Acarbose API Market Size Forecast by Type
5.2.1 Microbial Fermentation Process
5.2.2 Chemical Synthesis Process
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Acarbose API Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Acarbose API Market Size Forecast by Applications
6.2.1 Acarbose Tables
6.2.2 Acarbose Capsules
6.2.3 Acarbose Chewable Tables
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Acarbose API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Acarbose API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Acarbose API Analysis and Forecast
9.1 Introduction
9.2 North America Acarbose API Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Acarbose API Market Size Forecast by Type
9.6.1 Microbial Fermentation Process
9.6.2 Chemical Synthesis Process
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Acarbose API Market Size Forecast by Applications
9.10.1 Acarbose Tables
9.10.2 Acarbose Capsules
9.10.3 Acarbose Chewable Tables
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Acarbose API Analysis and Forecast
10.1 Introduction
10.2 Europe Acarbose API Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Acarbose API Market Size Forecast by Type
10.6.1 Microbial Fermentation Process
10.6.2 Chemical Synthesis Process
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Acarbose API Market Size Forecast by Applications
10.10.1 Acarbose Tables
10.10.2 Acarbose Capsules
10.10.3 Acarbose Chewable Tables
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Acarbose API Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Acarbose API Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Acarbose API Market Size Forecast by Type
11.6.1 Microbial Fermentation Process
11.6.2 Chemical Synthesis Process
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Acarbose API Market Size Forecast by Applications
11.10.1 Acarbose Tables
11.10.2 Acarbose Capsules
11.10.3 Acarbose Chewable Tables
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Acarbose API Analysis and Forecast
12.1 Introduction
12.2 Latin America Acarbose API Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Acarbose API Market Size Forecast by Type
12.6.1 Microbial Fermentation Process
12.6.2 Chemical Synthesis Process
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Acarbose API Market Size Forecast by Applications
12.10.1 Acarbose Tables
12.10.2 Acarbose Capsules
12.10.3 Acarbose Chewable Tables
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Acarbose API Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Acarbose API Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Acarbose API Market Size Forecast by Type
13.6.1 Microbial Fermentation Process
13.6.2 Chemical Synthesis Process
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Acarbose API Market Size Forecast by Applications
13.10.1 Acarbose Tables
13.10.2 Acarbose Capsules
13.10.3 Acarbose Chewable Tables
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Acarbose API Market: Competitive Dashboard
14.2 Global Acarbose API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Huadong Medicine Co.,Ltd
14.3.2 Zhejiang Hisun Pharmaceutical Co., Ltd.
14.3.3 Bayer
14.3.4 Livzon New North River Pharmaceutical Co., Ltd
